A DNA microarray study of nitric oxide-induced genes in mouse hepatocytes: Implications for hepatic heme oxygenase-1 expression in ischemia/reperfusion

Nitric Oxide - Biology and Chemistry

Volumn 7, Issue 3, 2002, Pages 165-186

  Zamora, Ruben ^a,c   Vodovotz, Yoram ^a   Aulak, Kulwant S ^b   Kim, Peter K M ^a   Kane Iii, John M ^a   Alarcon, Louis ^a   Stuehr, Dennis J ^b   Billiar, Timothy R ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; HEME OXYGENASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN; TRANSCRIPTION FACTOR; HEME OXYGENASE 1; HMOX1 PROTEIN, MOUSE; INDUCIBLE NITRIC OXIDE SYNTHASE; MEMBRANE PROTEIN; NOS2 PROTEIN, MOUSE;

ADENOVIRUS; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL ENERGY; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVITY; EXPERIMENTAL INFECTION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC CODE; ISCHEMIA; LIVER CELL; LIVER INJURY; MOUSE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REPERFUSION INJURY; VIRUS INFECTION; ANIMAL; BIOSYNTHESIS; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY;

ADENOVIRIDAE;

ANIMALS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HEPATOCYTES; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPERFUSION INJURY; TRANSFECTION;

EID: 1842834977     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-8603(02)00104-0     Document Type: Article

References (168)

1. H.E. Marshall, K. Merchant, J.S. Stamler, Nitrosation and oxidation in the regulation of gene expression, FASEB J. 14 (2000) 1889-1900.
2. Y. Vodovotz, M.H. Barcellos-HoG, Direct and Indirect Modulation of the Inducible Nitric Oxide Synthase by Nitric Oxide: Feedback Mechanisms in Inflammation, in: D. Salvemini, T.R. Billiar, Y. Vodovotz (Eds.), Nitric Oxide and Inflammation, Birkhauser-Verlag, Basel, 2001, pp. 41-58.
3. D.A. Wink, M. Feelisch, Y. Vodovotz, J. Fukuto, M.B. Grisham, The Chemical Biology of Nitric Oxide, in: C.A. Colton, D.L. Gilbert (Eds.), Reactive Oxygen Species in Biological Systems: An Inter Disciplinary Approach, KluwerAcademic/Plenum Publishing, New York, 1999, pp. 245-291.
4. J.D. MacMicking, C. Nathan, G. Horn, N. Chartrain, D.S. Fletcher, M. Trumbauer, K. Stevens, Q.-W. Xie, K. Sokol, N. Hutchinson, H. Chen, J.S. Mudgett, Altered responsesto bacterial infection and endotoxic shock in mice lacking induciblenitric oxide synthase, Cell 81 (1995) 641-650.
5. E. Tzeng, L.L. Shears II, P.D. Robbins, B.R. Pitt, D.A. Geller, S.C. Watkins, R.L. Simmons, T.R. Billiar, Vascular gene transfer of the human inducible nitric oxide synthase: Characterization of activity and effects on myointimal hyperplasia, Mol. Med. 2 (1996) 211-225.
6. B.V. De, N. Biglia, P. Sismondi, B.M. De, DNA chips: The future of biomarkers, Int. J. Biol. Markers 15 (2000) 1-9.
7. C.A. Harrington, C. Rosenow, J. Retief, Monitoring gene expression using DNA microarrays, Curr. Opin. Microbiol. 3 (2000) 285-291.
8. J.D. Macmicking, C. Nathan, G. Hom, N. Chartrain, D.S. Fletcher, M. Trumbauer, K. Stevens, Q.W. Xie, K. Sokol, N. Hutchinson, Altered responses to bacterial infection andendo-toxic shock in mice lacking inducible nitric oxide synthase, Cell 81(1995) 641-650.
9. P.O. Seglen, Preparation of isolated rat liver cells, Methods Cell Biol. 13 (1976) 29-83.
10. L.L. Shears, N. Kawaharada, E. Tzeng, T.R. Billiar, S.C. Watkins, I. Kovesdi, A. Lizonova, S.M. Pham, Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis, J. Clin. Invest. 100 (1997) 2035-2042.
11. C.J. Lowenstein, C.S. Glatt, D.S. Bredt, S.H. Snyder, Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme, Proc. Natl. Acad. Sci. USA 89 (1992) 6711-6715.
12. E.L. Yee, B.R. Pitt, T.R. Billiar, Y.M. Kim, Effect of nitric oxide on heme metabolism in pulmonary arteryendothelial cells, Am. J. Physiol. 271 (1996) L512-L518.
13. H. Tanimoto, Y. Yan, J. Clarke, S. Korourian, K. Shigemasa, T.H. Parmley, G.P. Parham, T.J. O'Brien, Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer, Cancer Res. 57 (1997) 2884-2887.
14. P.E. Goss, M.A. Baker, J.P. Carver, J.W. Dennis, Inhibitors of carbohydrate processing: A new class of anticancer agents, Clin. Cancer Res. 1 (1995) 935-944.
15. G.W. Reuther, C.J. Der, The Ras branch of small GTPases: Ras family members don't fall far from the tree, Curr. Opin. Cell Biol. 12 (2000) 157-165.
16. T. Tsukamoto, J. Yoo, S.I. Hwang, R.C. Guzman, Y. Hirokawa, Y.C. Chou, S. Olatunde, T. Huang, T.K. Bera, J. Yang, S. Nandi, Expression of MAT1/PEA-15 mRNA isoforms during physiological and neoplastic changes in the mouse mammary gland, Cancer Lett. 149 (2000) 105-113.
17. B. Dutrillaux, M. Muleris, Induction of increased salvage pathways of nucleotide synthesis by dosage effect due to chromosome imbalances may be fundamental in carcinogenesis: The example of colorectal carcinoma, Ann. Genet. 29 (1986) 11-15.
18. J.M. Balo-Banga, G. Weber, Increased 5-phospho-alpha-D-ribose-1-diphosphate synthetase (ribosephosphate pyrophosphokinase, EC 2.7.6.1) activity in rat hepatomas, Cancer Res. 44 (1984) 5004-5009.
19. S. Frank, S.B. von, E.H. Farthmann, T. Hirsch, Identification of genes involved in human mesothelial cancer progression using a modified differential display technique, Cancer Lett. 123 (1998) 7-14.
20. N. Takizawa, Y. Mizuno, M. Saadat, K. Kikuchi, Selective increases in isoform PP1 alpha of type-1 protein phosphatasein ascites hepatoma cells, Jpn. J. Cancer Res. 85 (1994) 274-278.
21. M. Saadat, K. Kitamura, Y. Mizuno, H. Saeki, T. Kudo, K. Kikuchi, Gene expression of protein phosphatases in rat ascites hepatoma cell lines, Cancer Detect. Prev. 18 (1994) 115-122.
22. J.E. Testa, P.C. Brooks, J.M. Lin, J.P. Quigley, Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis, Cancer Res. 59 (1999) 3812-3820.
23. G.J. Ruiz-Arguelles, M.J. San, Cell surface markers in multiple myeloma, Mayo Clin. Proc. 69 (1994) 684-690.
24. Y. Komada, M. Sakurai, Shedding of CD9 antigen inacute lymphoblastic leukemia, Leuk. Lymphoma. 12 (1994) 365-372.
25. T. Ishiguro, M. Nakajima, M. Naito, T. Muto, T. Tsuruo, Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials, Cancer Res. 56 (1996) 875-879.
26. K. Taketa, J. Shimamura, M. Ueda, Y. Shimada, K. Kosaka, Profiles of carbohydrate-metabolizing enzymes in human hepatocellular carcinomas and preneoplastic livers, Cancer Res. 48 (1988) 467-474.
27. M. Seto, K. Yamamoto, T. Takahashi, R. Ueda, Cloning and expression of a murine cDNA homologous to the human RCK/P54, a lymphoma-linked chromosomal translocation junction gene on 11q23, Gene 166 (1995) 293-296.
28. R. Lange, N. Ducloux, F. Perin, C. Larroque, L.J. van, F. Zajdela, Particular cytochrome P-450-dependent steroidmetabolism: A new class of mouse liver tumor markers, Carcinogenesis 10(1989) 1871-1877.
29. M. Cheng, P.H. Watson, J.A. Paterson, N. Seidah, M. Chretien, R.P. Shiu, Pro-protein convertase geneexpression in human breast cancer, Int. J. Cancer 71 (1997) 966-971.
30. A. Paradiso, G. Simone, S. Petroni, B. Leone, C. Vallejo, J. Lacava, A. Romero, M. Machiavelli, L.M. De, C.J. Allegra, P.G. Johnston, Thymidilate synthase and p53 primary tumour-expression as predictive factors for advanced colorectal cancer-patients, Br. J. Cancer 82 (2000) 560-567.
31. J.W. Clark, A.S. Glicksman, H.J. Wanebo, Systemic and adjuvant therapy for patients with pancreatic carcinoma, Cancer 78(1996) 688-693.
32. A.F. Chambers, A.B. Tuck, Ras-responsive genesand tumor metastasis, Crit. Rev. Oncog. 4 (1993) 95-114.
33. S. Menard, E. Tagliabue, M.I. Colnaghi, The 67kDalaminin receptor as a prognostic factor in human cancer, Breast Cancer Res. Treat. 52 (1998) 137-145.
34. R. Lim, W.X. Zhong, A. Zaheer, Antiproliferative function of glia maturation factor beta, Cell Regul. 1 (1990) 741-746.
35. A.S. Arora, G.P. de, D.E. Croall, Y. Emori, G.J. Gores, Hepatocellular carcinoma cells resist necrosis during anoxia by preventing phospholipase-mediated calpain activation, J. Cell Physiol. 167 (1996) 434-442.
36. D.A. Wink, Y. Vodovotz, J. Laval, F. Laval, M.W. Dewhirst, J.B. Mitchell, The multifaceted roles of NO in cancer, Carcinogenesis 19 (1998) 711-721.
37. C. Nathan, Nitric oxide as a secretory product ofmammalian cells, FASEB J. 6 (1992) 3051-3064.
38. J. Guo, M.R. Siegfried, A.M. Lefer, Endothelial preserving actions of a nitric oxide donor in carotidarterial intimal injury, Meth. Find. Exp. Clin. Pharmacol. 16 (1994) 347-354.
39. V. Krischel, D. Bruch-Gerharz, C. Suschek, K.D. Kroncke, T. Ruzicka, V. Kolb-Bachofen, Biphasic effect of exogenous nitric oxide on proliferation and differentiation in skin derived keratinocytes but not fibroblasts, J. Invest. Dermatol. 111 (1998) 286-291.
40. Y. Cai, S. Kitajima, F. Etoh, S. Kinoshita, K. Okubo, N. Hamasaki, Autoantibody reactive with the human general transcription factor TFIIF in sera from patients with autoimmune disorders, Clin. Exp. Immunol. 109 (1997) 488-494.
41. H.P. Holthoff, H. Hameister, R. Knippers, Anovel human Mcm protein: Homology to the yeast replication protein Mis5 and chromosomal location, Genomics 37 (1996) 131-134.
42. O.N. Denisenko, K. Bomsztyk, The product of themurine homolog of the Drosophila extra sex combs gene displays transcriptional repressor activity, Mol. Cell Biol. 17 (1997) 4707-4717.
43. Y. Akao, O. Marukawa, H. Morikawa, K. Nakao, M. Kamei, T. Hachiya, Y. Tsujimoto, The rck/p54 candidateproto-oncogene product is a 54-kilodalton D-E-A-D box protein differentially expressed in human and mouse tissues, Cancer Res 55 (1995) 3444-3449.
44. K.D. Kroncke, K. Fehsel, T. Schmidt, F.T. Zenke, I. Dasting, J.R. Wesener, H. Bettermann, K.D. Breunig, V. Kolb-Bachofen, Nitric oxide destroys zinc-sulfur clusters inducing zinc release from metallothionein and inhibition of the zincfinger-type yeast transcription activator LAC9, Biochem. Biophys. Res. Commun. 200 (1994) 1105-1110.
45. K.D. Kroncke, V. Kolb-Bachofen, Detection ofnitric oxide interaction with zinc finger proteins, Methods Enzymol. 269 (1996) 279-284.
46. D.A. Wink, J. Laval, The Fpg protein, a DNArepair enzyme, is inhibited by the biomediator nitric oxide in vitro and in vivo, Carcinogenesis 15 (1994) 2125-2129.
47. M. Lepoivre, F. Fieschi, J. Coves, L. Thelander, M. Fontecave, Inactivation of ribonucleotide reductase by nitricoxide, Biochem. Biophys. Res. Commun. 179 (1991) 442-448.
48. N.S. Kwon, D.J. Stuehr, C.F. Nathan, Inhibition of tumor cell ribonucleotide reductase by macrophage-derivednitric oxide, J. Exp. Med. 174 (1991) 761-767.
49. B.C. Varnum, R.W. Lim, V.P. Sukhatme, H.R. Herschman, Nucleotide sequence of a cDNA encoding TIS11 a message induced in Swiss 3T3 cells by the tumor promoter tetradecanoyl phorbol acetate, Oncogene 4 (1989) 119-120.
50. R. Raz, J.E. Durbin, D.E. Levy, Acute phaseresponse factor and additional members of the interferon-stimulated genefactor 3 family integrate diverse signals from cytokines, interferons, and growth factors, J. Biol. Chem. 269 (1994) 24391-24395.
51. R.T. Villavicencio, S. Liu, M.R. Kibbe, D.L. Williams, R.W. Ganster, K.F. Dyer, D.J. Tweardy, T.R. Billiar, B.R. Pitt, Induced nitric oxide inhibits IL-6-induced stat3 activation and type II acute phase mRNA expression, Shock 13 (2000) 441-445.
52. C. Szabo, T.R. Billiar, Novel roles of nitricoxide in hemorrhagic shock, Shock 12 (1999) 1-9.
53. J. Massague, TGF-beta signal transduction, Annu. Rev. Biochem. 67 (1998) 753-791.
54. Y. Vodovotz, Control of nitric oxide production by transforming growth factor-β1: Mechanistic insights and potential relevance to human disease, Nitric Oxide: Biol. and Chem. 1 (1997) 3-17.
55. H. Fu, R.R. Subramanian, S.C. Masters, 14-3-3 Proteins: Structure, function, regulation, Annu. Rev. Pharmacol. Toxicol. 40 (2000) 617-647.
56. F.S. Laroux, K.P. Pavlick, I.N. Hines, S. Kawachi, H. Harada, S. Bharwani, J.M. Hoffman, M.B. Grisham, Role of nitric oxide in inflammation, Acta Physiol Scand. 173 (2001) 113-118.
57. M.E. de Vera, R.A. Shapiro, A.K. Nussler, J.S. Mudgett, R.L. Simmons, S.M. Morris Jr., T.R. Billiar, D.A. Geller, Transcriptional regulation of human inducible nitric oxidesynthase (NOS2) gene by cytokines: Initial analysis of the human NOS2 promoter, Proc. Natl. Acad. Sci. USA 93 (1996) 1054-1059.
58. J.W. Christman, L.H. Lancaster, T.S. Blackwell, Nuclear factor kappa B: A pivotal role in the systemicinflammatory response syndrome and new target for therapy, Intensive. Care Med. 24 (1998) 1131-1138.
59. J.M. Griscavage, S. Wilk, L.J. Ignarro, Serine and cysteine proteinase inhibitors prevent nitric oxide production by activated macrophages by interfering with transcription of the inducible NO synthase gene, Biochem. Biophys. Res. Commun. 215 (1995) 721-729.
60. G. Walker, J. Pfeilschifter, D. Kunz, Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimulated RAW 264.7 cells by dexamethasone. Evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post-transcriptional regulation, J. Biol. Chem. 272 (1997) 16679-16687.
61. M. Michetti, F. Salamino, E. Melloni, S. Pontremoli, Reversible inactivation of calpain isoforms by nitric oxide, Biochem. Biophys. Res. Commun. 207 (1995) 1009-1014.
62. A.L. Bishop, A. Hall, Rho GTPases and their effector proteins, Biochem. J. 348 (2000) 241-255.
63. R. Muniyappa, R. Xu, J.L. Ram, J.R. Sowers, Inhibition of Rho protein stimulates iNOS expression in rat vascular smooth muscle cells, Am. J. Physiol. Heart Circ. Physiol. 278 (2000) H1762-H1768.
64. A.R. Simon, H.G. Vikis, S. Stewart, B.L. Fanburg, B.H. Cochran, K.L. Guan, Regulation of STAT3 by direct binding to the rac1 GTPase, Science 290 (2000) 144-147.
65. M. Ishino, T. Ohba, H. Sasaki, T. Sasaki, Molecular cloning of a cDNA encoding a phosphoprotein, Efs, which contains a Src homology 3 domain and associates with Fyn, Oncogene 11 (1995) 2331-2338.
66. N.P. Klein, R.J. Schneider, Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras, Mol. Cell Biol. 17 (1997) 6427-6436.
67. S.D. Briggs, S.S. Bryant, R. Jove, S.D. Sanderson, T.E. Smithgall, The Ras GTPase-activating protein GAP is an SH3 domain-binding protein and substrate for the Src-related tyrosine kinase, Hck, J. Biol. Chem. 270 (1995) 14718-14724.
68. N. Zhong, W. Ju, D. Nelson, C. Dobkin, W.T. Brown, Reduced mRNA for G3BP in fragile X cells: Evidence of FMR1 gene regulation, Am. J. Med. Genet. 84 (1999) 268-271.
69. R.D. Curran, T.R. Billiar, D.J. Stuehr, J.B. Ochoa, B.G. Harbrecht, S.G. Flint, R.L. Simmons, Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis, Ann. Surg. 212 (1990) 462-469.
70. S. Wouters, M. Leruth, E. Decroly, M. Vandenbranden, J.W. Creemers, J.W. van de Loo, J.M. Ruysschaert, P.J. Courtoy, Furin and proprotein convertase7 (PC7)/lymphoma PC endogenously expressed in rat liver can be resolved into distinct post-Golgicompartments, Biochem. J. 336 (1998) 311-316.
71. E.T. Yeh, L. Gong, T. Kamitani, Ubiquitin-likeproteins: New wines in new bottles, Gene 248 (2000) 1-14.
72. R. Urade, Y. Takenaka, M. Kito, Protein degradation by ERp72 from rat and mouse liver endoplasmic reticulum, J. Biol. Chem. 268 (1993) 22004-22009.
73. B.M. Pearse, Characterization of coated-vesicle adaptors: Their reassembly with clathrin and with recycling receptors, Methods Cell Biol. 31 (1989) 229-246.
74. A. Herscovics, Importance of glycosidases in mammalian glycoprotein biosynthesis, Biochim. Biophys. Acta 1473 (1999) 96-107.
75. M.N. Fukuda, HEMPAS Hereditary erythroblastic multinuclearity with positive acidified serum lysis test, Biochim. Biophys. Acta 1455 (1999) 231-239.
76. K. Tsurugi, E. Collatz, E.G. Wool, A. Lin, Isolation of eukaryotic ribosomal proteins. Purification and characterization of the 60 S ribosomal subunit proteins L4, L5, L7, L9, L11, L12, L13, L21, L22, L23, L26, L27, L30, L33, L35′, L37, L39, J. Biol. Chem. 251 (1976) 7940-7946.
77. T.R. Billiar, The delicate balance of nitric oxide and superoxide in liver pathology, Gastroenterology 108 (1995) 603-605.
78. K. Dobashi, K. Pahan, A. Chahal, I. Singh, Modulation of endogenous antioxidant enzymes by nitric oxide in rat C6 glial cells, J. Neurochem. 68 (1997) 1896-1903.
79. S. Kurata, M. Matsumoto, U. Yamashita, Concomitant transcriptional activation of nitric oxide synthase and hemeoxygenase genes during nitric oxide-mediated macrophage cytostasis, J. Biochem. 120 (1996) 49-52.
80. K. Arizono, S. Kagawa, H. Hamada, T. Ariyoshi, Nitric oxide mediated metallothionein induction by lipopolysaccharide, Res. Commun. Mol. Pathol. Pharmacol. 90 (1995) 49-58.
81. C.R. Byrne, P.J. Hanson, Induction of heat-shock protein 72 by a nitric oxide donor in guinea-pig gastric mucosal cells, Eur. J. Pharmacol. 353 (1998) 117-122.
82. H.R. Wong, M. Ryan, I.Y. Menendez, A. Denenberg, J.R. Wispe, Heat shock protein induction protects human respiratory epithelium against nitric oxide-mediated cytotoxicity, Shock 8 (1997) 213-218.
83. M.E. de Vera, J.M. Wong, J.Y. Zhou, E. Tzeng, H.R. Wong, T.R. Billiar, D.A. Geller, Cytokine-induced nitric oxide synthase gene transcription is blocked by the heat-shock response in human liver cells, Surgery 120 (1996) 144-149.
84. O.W. Griffith, Biologic and pharmacologic regulation of mammalian glutathione synthesis, Free Radic. Biol. Med. 27 (1999) 922-935.
85. R.A. Mazzarella, M. Srinivasan, S.M. Haugejorden, M. Green, ERp72, an abundant luminal endoplasmic reticulum protein, contains three copies of the active site sequences of protein disulfide isomerase, J. Biol. Chem. 265 (1990) 1094-1101.
86. A.J. Dorner, L.C. Wasley, P. Raney, S. Haugejorden, M. Green, R.J. Kaufman, The stress response in Chinese hamster ovary cells. Regulation of ERp72 and protein disulfide isomerase expression and secretion, J. Biol. Chem. 265 (1990) 22029-22034.
87. T. Miron, K. Vancompernolle, J. Vandekerckhove, M. Wilchek, B. Geiger, A 25-kD inhibitor of actin polymerization is a low molecular mass heat-shock protein, J. Cell Biol. 114 (1991) 255-261.
88. J. Honkaniemi, J. Kononen, T. Kainu, I. Pyykonen, M. Pelto-Huikko, Induction of multiple immediate early genes in rat hypothalamic paraventricular nucleus after stress, Brain Res. Mol. Brain Res. 25 (1994) 234-241.
89. F.V. Leeuwen, R. Wever, B.V. Gelder, EPR study of nitric oxide-treated reduced ceruloplasmin, Biochim. Biophys. Acta 315 (1973) 200-203.
90. R. Wever, F.V. Leeuwen, B.v. Gelder, The reaction of nitric oxide with ceruloplasmin, Biochim. Biophys. Acta 302 (1973) 236-239.
91. A.P. Dicks, D.L. Williams, Generation of nitricoxide from S-nitrosothiols using protein-bound Cu2+ sources, Chem. Biol. 3 (1996) 655-659.
92. K. Inoue, T. Akaike, Y. Miyamoto, T. Okamoto, T. Sawa, M. Otagiri, S. Suzuki, T. Yoshimura, H. Maeda, Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo, J. Biol. Chem. 274 (1999) 27069-27075.
93. M. Wessling-Resnick, Biochemistry of iron uptake, Crit. Rev. Biochem. Mol. Biol. 34 (1999) 285-314.
94. N. Kawada, T. Kuroki, M. Uoya, M. Inoue, K. Kobayashi, Smooth muscle alpha-actin expression in rat hepatic stellate cell is regulated by nitric oxide and cGMP production, Biochem. Biophys. Res. Commun. 229 (1996) 238-242.
95. H.I. Magazine, J. Chang, Y. Goumon, G.B. Stefano, Rebound from nitric oxide inhibition triggers enhanced monocyte activation and chemotaxis, J. Immunol. 165 (2000) 102-107.
96. D. Hofer, T. Jons, J. Kraemer, D. Drenckhahn, From cytoskeleton to polarity and chemoreception in the gut epithelium, Ann. NY Acad. Sci. 859 (1998) 75-84.
97. J.Y. Dube, P. Chapdelaine, P.L. Trahan, D. Deperthes, G. Frenette, R.R. Tremblay, Abundant cysteine-richprotein-1 is localized in the stromal compartment of the human prostate, Arch. Androl. 40 (1998) 109-115.
98. J.D. Sutherland, W. Witke, Molecular genetic approaches to understanding the actin cytoskeleton, Curr. Opin. Cell Biol. 11 (1999) 142-151.
99. A.V. Grinberg, F. Hannemann, B. Schiffler, J. Muller, U. Heinemann, R. Bernhardt, Adrenodoxin: Structure, stability, electron transfer properties, Proteins (2000) 40, 590-612.
100. M.R. Waterman, E.R. Simpson, Regulation of the biosynthesis of cytochromes P-450 involved in steroid hormone synthesis, Mol. Cell Endocrinol. 39 (1985) 81-89.
101. D.E. Cohen, M.R. Leonard, M.C. Carey, In vitro evidence that phospholipid secretion into bile may be coordinated intracellularly by the combined actions of bile salts and the specific phosphatidylcholine transfer protein of liver, Biochemistry 33 (1994) 9975-9980.
102. A.C. Nicholson, M. Febbraio, J. Han, R.L. Silverstein, D.P. Hajjar, CD36 in atherosclerosis. The role of a class B macrophage scavenger receptor, Ann. NY Acad. Sci. 902 (2000) 128-131.
103. T.M. Mason, The role of factors that regulate the synthesis and secretion of very-low-density lipoprotein by hepatocytes, Crit. Rev. Clin. Lab. Sci. 35 (1998) 461-487.
104. Y. Deyashiki, K. Ohshima, M. Nakanishi, K. Sato, K. Matsuura, A. Hara, Molecular cloning and characterization of mouse estradiol 17 beta-dehydrogenase A-specific, a member of the aldoketoreductase family, J. Biol. Chem. 270 (1995) 10461-10467.
105. P. Muriel, G. Sandoval, Nitric oxide and peroxynitrite anion modulate liver plasma membrane fluidity and Na(+)/K(+)-ATPase activity, Nitric Oxide 4 (2000) 333-342.
106. C. Romeo, S. Eaton, L. Spitz, A. Pierro, Nitric oxide inhibits neonatal hepatocyte oxidative metabolism, J. Pediatr. Surg. 35 (2000) 44-48.
107. + ATPases in peritoneal macrophages, J. Exp. Med. 174 (1991) 1009-1021.
108. A. Tojo, N.J. Guzman, L.C. Garg, C.C. Tisher, K.M. Madsen, Nitric oxide inhibits bafilomycin-sensitive H(+)-ATPase activity in rat cortical collecting duct, Am. J. Physiol. 267 (1994) F509-F515.
109. M. Forgac, The vacuolar H+-ATPase of clathrin-coated vesicles is reversibly inhibited by S-nitrosoglutathione, J. Biol. Chem. 274 (1999) 1301-1305.
110. S. Levy, S.C. Todd, H.T. Maecker, CD81TAPA-1: A molecule involved in signal transduction and cell adhesion in the immune system, Annu. Rev. Immunol. 16 (1998) 89-109.
111. P. Pileri, Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A.J. Weiner, M. Houghton, D. Rosa, G. Grandi, S. Abrignani, Binding of hepatitis C virus to CD81, Science 282 (1998) 938-941.
112. J.M. Kane III, L.L. Shears, C. Hierholzer, S. Ambs, T.R. Billiar, M.C. Posner, Chronic hepatitis C virus infection in humans: Induction of hepatic nitric oxide synthase and proposed mechanisms for carcinogenesis, J. Surg. Res. 69 (1997) 321-324.
113. B.D. Cohen, D.R. Lowy, J.T. Schiller, The conserved C-terminal domain of the bovine papillomavirus E5 oncoprotein can associate with an alpha-adaptin-like molecule: A possible link between growth factor receptors and viral transformation, Mol. Cell Biol. 13 (1993) 6462-6468.
114. B.A. Puffer, S.C. Watkins, R.C. Montelaro, Equine infectious anemia virus Gag polyprotein late domain specifically recruits cellular AP-2 adapter protein complexes during virion assembly, J. Virol. 72 (1998) 10218-10221.
115. R. Volpes, J.J. van den Oord, V.J. Desmet, Adhesive molecules in liver disease. Immunohistochemical distribution of thrombospondin receptors in chronic HBV infection, J. Hepatol. 10 (1990) 297-304.
116. M.M. Mota, W. Jarra, E. Hirst, P.K. Patnaik, A.A. Holder, Plasmodium chabaudi-infected erythrocytes adhere to CD36 and bind to microvascular endothelial cells in an organ-specific way, Infect. Immun. 68 (2000) 4135-4144.
117. H. Sartelet, O. Garraud, C. Rogier, I. Milko-Sartelet, Y. Kaboret, G. Michel, C. Roussilhon, M. Huerre, D. Gaillard, Hyperexpression of ICAM-1 and CD36 in placentas infected with Plasmodium falciparum: A possible role of these molecules in sequestration of infected red blood cells in placentas, Histopathology 36 (2000) 62-68.
118. F. Lanza, L. Ferrari, L. Sighinolfi, F. Ghinelli, A. Latorraca, S. Moretti, L. Trevisani, A. Potena, F. Malavasi, G. Castoldi, Reduced expression of macrophage-associated antigens on alveolar mononuclear phagocytes from acquired immuno deficiency syndrome, Int. J. Clin. Lab. Res. 23 (1993) 146-150.
119. J. Sobajima, S. Ozaki, H. Uesugi, F. Osakada, M. Inoue, Y. Fukuda, H. Shirakawa, M. Yoshida, A. Rokuhara, H. Imai, K. Kiyosawa, K. Nakao, High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis, Gut 44 (1999) 867-873.
120. R.A. Ezekowitz, L.E. Day, G.A. Herman, A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins, J. Exp. Med. 167 (1988) 1034-1046 (published erratum appears in J Exp Med 1991 Sep 1;174 (3):753).
121. P. Tabona, A. Mellor, J.A. Summerfield, Mannose binding protein is involved in first-line host defence: Evidence from transgenic mice, Immunology 85 (1995) 153-159.
122. M.S. Mulligan, J.S. Warren, C.W. Smith, D.C. Anderson, C.G. Yeh, A.R. Rudolph, P.A. Ward, Lung injury after deposition of IgA immune complexes. Requirements for CD18 and L-arginine, J. Immunol. 148 (1992) 3086-3092.
123. P.J. Vickers, 5-Lipoxygenase-activating protein (FLAP), J. Lipid Mediat. Cell Signal. 12 (1995) 185-194.
124. J.M. Drazen, Asthma therapy with agents preventing leukotriene synthesis or action, Proc. Assoc. Am. Physicians. 111 (1999) 547-559.
125. P. Munoz-Canoves, B.F. Tack, D.P. Vik, Analysis of complement factorH mRNA expression: Dexamethasone and IFN-gamma increase the level of H in L cells, Biochemistry 28 (1989) 9891-9897.
126. J. Cheng, K.J. Macon, J.E. Volanakis, cDNA cloning and characterization of the protein encoded by RD, a gene located in the class III region of the human major histocompatibility complex, Biochem. J. 294 (1993) 589-593.
127. A. Zaheer, B.D. Fink, R. Lim, Expression of glia maturation factor beta mRNA and protein in rat organs and cells, J. Neurochem. 60 (1993) 914-920.
128. N.J. Pantazis, A. Zaheer, D. Dai, S. Zaheer, S.H. Green, R. Lim, Transfection of C6 glioma cells with glia maturation factor upregulates brain-derived neurotrophic factor and nerve growth factor: Trophic effects and protection against ethanol toxicity in cerebellar granule cells, Brain Res. 865 (2000) 59-76.
129. S. Dimmeler, A.M. Zeiher, Nitric oxide and apoptosis: Another paradigm for the double-edged role of nitric oxide, Nitric Oxide: Biol. and Chem. 1 (1997) 275-281.
130. J. Li, T.R. Billiar, The anti-apoptotic actions of nitric oxide in hepatocytes, Cell Death. Differ. 6 (1999) 952-955.
131. S.G. Ahn, G.H. Cho, S.Y. Jeong, H. Rhim, J.Y. Choi, I.K. Kim, Identification of cDNAs for Sox-4, an HMG-Boxprotein, a novel human homolog of yeast splicing factor SSF-1 differentially regulated during apoptosis induced by prostaglandin A2/delta 12-PGJ2 in Hep3B cells, Biochem. Biophys. Res. Commun. 260 (1999) 216-221.
132. M. Nakata, N. Uto, I. Maruyama, T. Yada, Nitric oxide induces apoptosis via Ca2+-dependent processes in the pancreatic beta-cell line MIN6, Cell Struct. Funct. 24 (1999) 451-455.
133. H.G. Wang, J.A. Millan, A.D. Cox, C.J. Der, U.R. Rapp, T. Beck, H. Zha, J.C. Reed, R-Ras promotes apoptosis caused by growth factor deprivation via a Bcl-2 suppressible mechanism, J. Cell Biol. 129 (1995) 1103-1114.
134. T.S. Juan, I.K. McNiece, N.A. Jenkins, D.J. Gilbert, N.G. Copeland, F.A. Fletcher, Molecular characterization of mouse and rat CPP32 beta gene encoding a cysteine protease resembling interleukin-1 beta converting enzyme and CED-3, Oncogene 13 (1996) 749-755.
135. G. Condorelli, G. Vigliotta, A. Cafieri, A. Trencia, P. Andalo, F. Oriente, C. Miele, M. Caruso, P. Formisano, F. Beguinot, PED/PEA-15: An anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis, Oncogene 18 (1999) 4409-4415.
136. Y. Moriwaki, T. Yamamoto, K. Higashino, Enzymes involved in purine metabolism - A review of histochemical localization and functional implications, Histol. Histopathol. 14 (1999) 1321-1340.
137. D. Cournoyer, C.T. Caskey, Gene therapy of the immune system, Annu. Rev. Immunol. 11 (1993) 297-329.
138. M. Tatibana, K. Kita, M. Taira, S. Ishijima, T. Sonoda, T. Ishizuka, T. Iizasa, I. Ahmad, Mammalian phosphoribosyl-pyrophosphate synthetase, Adv. Enzyme Regul. 35 (1995) 229-249.
139. N.L. Edwards, I.H. Fox, Disorders associated with purine and pyrimidine metabolism, Spec. Top. Endocrinol. Metab. 6 (1984) 95-140.
140. M.A. Becker, J.M. Nosal, R.L. Switzer, P.R. Smith, T.D. Palella, B.J. Roessler, Point mutations in PRPS1, the gene encoding the PRPP synthetase (PRS) 1 isoform, underlie X-linked PRS superactivity associated with purine nucleotide inhibitor-resistance, Adv. Exp. Med. Biol. 370 (1994) 707-710.
141. S. Nagaki, M. Yamamoto, Y. Yumoto, H. Shirakawa, M. Yoshida, H. Teraoka, Non-histone chromosomal proteins HMG1 and 2 enhance ligation reaction of DNA double-strand breaks, Biophys. Res. Commun. 246 (1998) 137-141.
142. S.S. Parikh, C.D. Mol, D.J. Hosfield, J.A. Tainer, Envisioning the molecular choreography of DNA base excision repair, Curr. Opin. Struct. Biol. 9 (1999) 37-47.
143. A.F. Nichols, P. Ong, S. Linn, Mutations specific to the xeroderma pigmentosum group E Ddb- phenotype, J. Biol. Chem. 271 (1996) 24317-24320.
144. D.A. Wink, K.S. Kasprzak, C.M. Maragos, R.K. Elespuru, M. Misra, T.M. Dunams, T.A. Cebula, W.H. Koch, A.W. Andrews, J.S. Allen, DNA deaminating ability and genotoxicity of nitric oxide and its progenitors, Science 254 (1991) 1001-1003.
145. S.A. Lipton, Y.-B. Choi, Z.-H. Pan, S.Z. Lei, H.S.V. Chen, N.J. Sucher, J. Loscalzo, D.J. Singel, J.S. Stamler, A redox-based mechanism for the neuroprotective effects of nitric oxide and related compounds, Nature 364 (1993) 626-632.
146. L. Xu, J.P. Eu, G. Meissner, J.S. Stamler, Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation, Science 279 (1998) 234-237.
147. S.B. Mustafa, M.S. Olson, Effects of calcium channel antagonists on LPS-induced hepatic iNOS expression, Am. J. Physiol. 277 (1999) G351-G360.
148. R. Hawkins, Disseminated intravascular coagulation, Clin. J. Oncol. Nurs. 3 (1999) 127-131.
149. M.L. Johnson, T.R. Billiar, Roles of nitric oxide in surgical infection and sepsis, World J. Surg. 22 (1998) 187-196.
150. S.P. Leytus, K.R. Loeb, F.S. Hagen, K. Kurachi, E.W. Davie, A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells, Biochemistry 27 (1988) 1067-1074.
151. H. Do, J.F. Healey, E.K. Waller, P. Lollar, Expression of factor VIII by murine liver sinusoidal endothelial cells, J. Biol. Chem. 274 (1999) 19587-19592.
152. Z. Yan, T. Yokota, W. Zhang, G.K. Hansson, Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery, Circ. Res. 79 (1996) 38-44.
153. G. Condorelli, G. Vigliotta, C. Iavarone, M. Caruso, C.G. Tocchetti, F. Andreozzi, A. Cafieri, M.F. Tecce, P. Formisano, L. Beguinot, F. Beguinot, PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus, EMBO J. 17 (1998) 3858-3866.
154. T. Muramatsu, Essential roles of carbohydrate signals in development, immune response and tissue functions, as revealed by gene targeting, J. Biochem. Tokyo. 127 (2000) 171-176.
155. T. Fukada, K. Iida, N. Kioka, H. Sakai, T. Komano, Cloning of a cDNA encoding N-acetylglucosaminyltransferase I from rat liver and analysis of its expression in rat tissues, Biosci. Biotechnol. Biochem. 58 (1994) 200-201.
156. T. Fukada, N. Kioka, J. Nishiu, S. Sakata, H. Sakai, M. Yamada, T. Komano, Different response to inflammation of the multiple mRNAs of rat N-acetylglucosaminyl transferase I with variable 5′-untranslated sequences, FEBS Lett. 436 (1998) 228-232.
157. H. Rensing, I. Bauer, V. Datene, C. Patau, B.H. Pannen, M. Bauer, Differential expression pattern of hemeoxygenase-1/heat-shock protein 32 and nitric oxide synthase-II and their impact on liver injury in a rat model of hemorrhage and resuscitation, Crit. Care Med. 27 (1999) 2766-2775.
158. F. Amersi, R. Buelow, H. Kato, B. Ke, A.J. Coito, X.D. Shen, D. Zhao, J. Zaky, J. Melinek, C.R. Lassman, J.K. Kolls, J. Alam, T. Ritter, H.D. Volk, D.G. Farmer, R.M. Ghobrial, R.W. Busuttil, J.W. Kupiec-Weglinski, Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury, J. Clin. Invest 104 (1999) 1631-1639.
159. A.B. Peitzman, T.R. Billiar, B.G. Harbrecht, E. Kelly, A.O. Udekwu, R.L. Simmons, Hemorrhagic shock, Curr. Probl. Surg. 32 (1995) 925-1002.
160. Y. Horie, R. Wolf, D.N. Granger, Role of nitric oxide in gut ischemia-reperfusion-induced hepatic microvascular dysfunction, Am. J. Physiol. 273 (1997) G1007-G1013.
161. Y.M. Kim, H. Bergonia, J.R. Lancaster Jr., Nitrogen oxide-induced autoprotection in isolated rat hepatocytes, FEBS Lett. 374 (1995) 228-232.
162. R. Motterlini, A. Hidalgo, I. Sammut, K.A. Shah, S. Mohammed, K. Srai, C.J. Green, A precursor of the nitric oxide donor SIN-1 modulates the stress protein heme oxygenase-1 in rat liver, Biochem. Biophys. Res. Commun. 225 (1996) 167-172.
163. B.S. Taylor, Y.M. Kim, Q. Wang, R.A. Shapiro, T.R. Billiar, D.A. Geller, Nitric oxide down-regulates hepatocyte-inducible nitric oxide synthase gene expression, Arch. Surg. 132 (1997) 1177-1183.
164. K. Sase, T. Michel, Expression and regulation of endothelial nitric oxide synthase, Trends Cardiovasc. Med. 7 (1997) 28-37.
165. V.L. Dawson, T.M. Dawson, Nitric oxide inneuronal degeneration, Proc. Soc. Exp. Biol. Med. 211 (1996) 33-40.
166. H.J. Cho, Q.-W. Xie, J. Calaycay, R.A. Mumford, K.M. Siderek, T.D. Lee, C. Nathan, Calmodulin is a subunit of nitric oxide synthase from macrophages, J. Exp. Med. 176 (1992) 599-604.
167. Y. Ikeda, G. Toda, N. Hashimoto, S. Aotsuka, R. Yokohari, T. Maruyama, H. Oka, Anticalmodulin autoantibody in liverdiseases: A new antibody against a cytoskeleton-related protein, Hepatology 7 (1987) 285-293.
168. S. Ehrt, D. Schnappinger, S. Bekiranov, J. Drenkow, S. Shi, T.R. Gingeras, T. Gaasterland, G. Schoolnik, C. Nathan, Reprogramming of the macrophage transcriptome in response to interferon- gamma and Mycobacterium tuberculosis: Signaling roles of nitric oxide synthase-2 and phagocyte oxidase, J. Exp. Med. 194 (2001) 1123-1140.